Latest On MediPharm Labs Corp (MEDIF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-15 19:47 EST | News | MediPharm Labs GAAP EPS of -C$0.01, revenue of C$5.84M | N/A |  |
| 2023-05-15 19:46 EST | News | MediPharm Labs Corp. (MEDIF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-04-13 15:50 EST | News | MediPharm to cut ~30% staff amid restructuring | N/A | |
| 2023-04-07 00:37 EST | News | Vivo Cannabis reports Q4 results | N/A | |
| 2022-12-23 03:14 EST | News | MediPharm Labs to acquire VIVO Cannabis in all-equity transaction | N/A | |
| 2022-11-14 21:12 EST | News | MediPharm Labs Corp. (MEDIF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-08-16 03:08 EST | News | MediPharm Labs Corp. (MEDIF) CEO David Pidduck on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-11 13:51 EST | News | MediPharm Labs enters $6.2M for the sale of Australian facility | N/A | |
| 2022-05-17 02:09 EST | News | MediPharm Labs (MEDIF) CEO, David Pidduck on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-17 02:09 EST | News | MediPharm Q1 net loss narrows; expects top-line to improve in Q2 | N/A | |
| 2022-04-20 08:42 EST | News | David Pidduck is the new CEO of MediPharm Labs | N/A | |
| 2022-04-01 01:24 EST | News | MediPharm Labs reports Q4 results | N/A | |
| 2022-02-23 11:27 EST | News | MediPharm Labs files DMF with FDA for CBD manufacturing | N/A | |
| 2021-11-22 17:18 EST | News | MediPharm Labs: The Pharmaceutical Cannabis Play | N/A | |
| 2021-11-15 19:09 EST | News | MediPharm Labs Corp. (MEDIF) CEO Bryan Howcroft on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-31 21:39 EST | News | MediPharm Labs’ CBD50 candidate to advance in mid-stage trial for insomnia | N/A | |
| 2021-08-18 23:56 EST | News | MediPharm Labs gets export authorization to ship medical cannabis to Brazil | N/A | |
| 2021-08-17 07:23 EST | News | MediPharm Labs Corp. (MEDIF) CEO Keith Strachan on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 16:58 EST | News | Medipharm extends ADREXpharma partnership for cannabis in Germany | N/A | |
| 2021-07-22 16:57 EST | News | MediPharm Labs inks research agreement with McMaster University | N/A | |
| 2021-07-22 16:55 EST | News | MediPharm Labs receives Canadian GMP pharmaceutical drug establishment licence | N/A | |
| 2021-04-13 08:23 EST | News | Adjupharm inks supply agreement with Medipharm Labs | N/A | |
| 2021-04-06 15:09 EST | News | MediPharm Labs exports cannabis oil products first shipment to Germany | N/A | |
| 2021-04-01 10:29 EST | News | MediPharm Labs and STADA commence first sales in Germany under turnkey supply agreement | N/A | |
| 2021-03-31 14:59 EST | News | MediPharm Labs beats on revenue | N/A | |
| 2021-03-09 11:06 EST | News | MediPharm Labs ties up with Société Quebecois in Quebec supply deal | N/A | |
| 2021-03-08 16:10 EST | News | MediPharm Labs Australia signs supply and manufacturing agreement with Cannim | N/A | |
| 2021-03-03 01:23 EST | News | MediPharm ups size of capital raise to $29M | N/A | |
| 2021-03-02 06:45 EST | News | MediPharm Labs enters $20M bought deal equity financing | N/A | |
| 2021-02-24 20:29 EST | News | MediPharm: We Were Wrong | N/A | |
| 2021-02-24 02:39 EST | News | MediPharm Labs: Undiscovered Gem In The Cannabis Sector | N/A | |
| 2021-02-17 15:37 EST | News | MediPharm Labs wins Cannabis Drug Licence from Health Canada | N/A | |
| 2021-01-29 12:17 EST | News | New finance chief for MediPharm Labs | N/A | |
| 2020-12-04 06:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 08:26 EST | News | MediPharm Labs Corp. 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-11-18 05:01 EST | News | MediPharm Labs reports Q3 results | N/A | |
| 2020-11-18 05:01 EST | News | MediPharm Labs (MEDIF) CEO, Pat McCutcheon on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-17 23:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 14:53 EST | News | MediPharm Labs CFO resigns | N/A | |
| 2020-10-22 14:04 EST | News | MediPharm Labs' Australia subsidiary inks deal with Sunco Green Pharma | N/A | |
| 2020-10-19 12:55 EST | News | MediPharm Labs commences clinical trial for use of cannabis to treat chronic kidney disease patients | N/A | |
| 2020-10-08 21:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-06 02:03 EST | News | MediPharm inks medical cannabis supply deal with STADA | N/A | |
| 2020-10-04 15:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-28 15:59 EST | News | MediPharm Labs takes 100% ownership in MediPharm Labs Australia | N/A | |
| 2020-09-26 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-25 09:43 EST | News | MediPharm Labs inks supply agreement with DanCann; forays into Denmark | N/A | |
| 2020-09-22 19:53 EST | News | MediPharm Labs inks distribution pact with XLR8 Brazil | N/A | |
| 2020-09-17 09:15 EST | Financials | Company financials have been released. | Neutral | |
About MediPharm Labs Corp (MEDIF):
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to licensed cultivators in Canada. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.
General
- Name MediPharm Labs Corp
- Symbol MEDIF
- Type Common Stock
- Exchange OTCQX
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 230
- Fiscal Year EndDecember
- Web URLhttp://www.medipharmlabs.com
View More
Valuation
- Trailing PE 191.03
- Price/Sales (Trailing 12 Mt.) 1.16
- Price/Book (Most Recent Quarter) 1.22
- Enterprise Value Revenue 1.58
- Enterprise Value EBITDA 12.13
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin -62%
- Return on Assets -17%
- Return on Equity -34%
- Revenue Per Share $0
- Gross Profit 42.91 million
- Quarterly Earnings Growth -88.6%
View More
Highlights
- Market Capitalization 99.75 million
View More
Share Statistics
- Shares Outstanding 257.95 million
- Shares Float 139.98 million
- % Held by Insiders 1442%
- % Held by Institutions 14.96%
View More
Technicals
- Beta 0.81
- 52 Week High $1.7
- 52 Week Low $0.35
- 50 Day Moving Average 0.52
- 200 Day Moving Average 0.53
View More
Dividends
- Dividend Date 2018-10-04
- ExDividend Date N/A
- Dividend Yield 0%
View More
MediPharm Labs Corp (MEDIF) Dividend Calendar:
MEDIF's last dividend payment was made to shareholders on October 4, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
MediPharm Labs Corp (MEDIF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-16 | $N/A | -$0.11 | -$0.03 | -266.67% |
| 2020-06-30 | 2020-09-30 | $N/A | -$0.08 | -$0.04 | -106.5% |
| 2020-03-31 | 2020-06-30 | $N/A | -$0.01 | -$0.01 | -47% |
| 2019-12-31 | 2020-03-31 | $32.44 million | -$0.09 | $0.01 | -1024% |
| 2019-09-30 | 2019-12-31 | $43.39 million | -$0.02 | $0.03 | -169.33% |
| 2019-06-30 | 2019-09-30 | $31.47 million | $0.02 | $0.01 | 51% |
| 2019-03-31 | 2019-06-30 | $21.95 million | $0.01 | -$0.01 | 176% |
| 2018-12-31 | 2019-03-31 | $10.2 million | $-0.00 | ||
| 2018-09-30 | 2018-12-31 | $N/A | -$0.03 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $N/A | -$0.02 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $N/A | -$0.02 | $0.00 | |
| 2017-12-31 | 2018-03-31 | -$0.02 | $0.00 | ||
| 2017-09-30 | 2017-12-31 | -$0.01 | $0.00 | ||
| 2017-06-30 | 2017-09-30 | -$0.01 | $0.00 | ||
| 2017-03-31 | 2017-06-30 | -$0.01 | $0.00 | ||
| 2016-12-31 | 2017-03-31 | -$0.03 | $0.00 |
MediPharm Labs Corp (MEDIF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
MediPharm Labs Corp (MEDIF) Chart:
MediPharm Labs Corp (MEDIF) News:
Below you will find a list of latest news for MediPharm Labs Corp (MEDIF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
MediPharm Labs Corp (MEDIF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
MediPharm Labs Corp (MEDIF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|